ARTL
Price
$4.51
Change
+$0.16 (+3.68%)
Updated
Sep 5 closing price
Capitalization
5.96M
PHIO
Price
$2.04
Change
-$0.02 (-0.97%)
Updated
Sep 5 closing price
Capitalization
11.68M
Interact to see
Advertisement

ARTL vs PHIO

Header iconARTL vs PHIO Comparison
Open Charts ARTL vs PHIOBanner chart's image
Artelo Biosciences
Price$4.51
Change+$0.16 (+3.68%)
Volume$235.5K
Capitalization5.96M
Phio Pharmaceuticals
Price$2.04
Change-$0.02 (-0.97%)
Volume$30.81K
Capitalization11.68M
ARTL vs PHIO Comparison Chart in %
Loading...
ARTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARTL vs. PHIO commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARTL is a Hold and PHIO is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (ARTL: $4.51 vs. PHIO: $2.04)
Brand notoriety: ARTL and PHIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARTL: 71% vs. PHIO: 2%
Market capitalization -- ARTL: $5.96M vs. PHIO: $11.68M
ARTL [@Biotechnology] is valued at $5.96M. PHIO’s [@Biotechnology] market capitalization is $11.68M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARTL’s FA Score shows that 0 FA rating(s) are green whilePHIO’s FA Score has 0 green FA rating(s).

  • ARTL’s FA Score: 0 green, 5 red.
  • PHIO’s FA Score: 0 green, 5 red.
According to our system of comparison, PHIO is a better buy in the long-term than ARTL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARTL’s TA Score shows that 4 TA indicator(s) are bullish while PHIO’s TA Score has 4 bullish TA indicator(s).

  • ARTL’s TA Score: 4 bullish, 6 bearish.
  • PHIO’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both ARTL and PHIO are a bad buy in the short-term.

Price Growth

ARTL (@Biotechnology) experienced а -51.24% price change this week, while PHIO (@Biotechnology) price change was +3.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHIO($11.7M) has a higher market cap than ARTL($5.96M). PHIO YTD gains are higher at: 13.333 vs. ARTL (-29.088). PHIO has higher annual earnings (EBITDA): -7.45M vs. ARTL (-10.71M). PHIO has more cash in the bank: 10.8M vs. ARTL (2.07M). PHIO has less debt than ARTL: PHIO (0) vs ARTL (878K). ARTL (0) and PHIO (0) have equivalent revenues.
ARTLPHIOARTL / PHIO
Capitalization5.96M11.7M51%
EBITDA-10.71M-7.45M144%
Gain YTD-29.08813.333-218%
P/E RatioN/A0.01-
Revenue00-
Total Cash2.07M10.8M19%
Total Debt878K0-
FUNDAMENTALS RATINGS
ARTL vs PHIO: Fundamental Ratings
ARTL
PHIO
OUTLOOK RATING
1..100
5962
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
54
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
9562
P/E GROWTH RATING
1..100
10063
SEASONALITY SCORE
1..100
840

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PHIO's Valuation (54) in the Biotechnology industry is in the same range as ARTL (61) in the null industry. This means that PHIO’s stock grew similarly to ARTL’s over the last 12 months.

PHIO's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ARTL (100) in the null industry. This means that PHIO’s stock grew similarly to ARTL’s over the last 12 months.

PHIO's SMR Rating (99) in the Biotechnology industry is in the same range as ARTL (100) in the null industry. This means that PHIO’s stock grew similarly to ARTL’s over the last 12 months.

PHIO's Price Growth Rating (62) in the Biotechnology industry is somewhat better than the same rating for ARTL (95) in the null industry. This means that PHIO’s stock grew somewhat faster than ARTL’s over the last 12 months.

PHIO's P/E Growth Rating (63) in the Biotechnology industry is somewhat better than the same rating for ARTL (100) in the null industry. This means that PHIO’s stock grew somewhat faster than ARTL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARTLPHIO
RSI
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 9 days ago
78%
Bullish Trend 16 days ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ARTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DOMH5.850.17
+2.99%
Dominari Holdings
ASGN53.070.62
+1.18%
ASGN
TTNP4.23-0.02
-0.36%
Titan Pharmaceuticals
PGC28.90-0.15
-0.52%
Peapack-Gladstone Financial Corp
MTZ178.00-4.51
-2.47%
MasTec

ARTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARTL has been loosely correlated with MTNB. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ARTL jumps, then MTNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARTL
1D Price
Change %
ARTL100%
+3.68%
MTNB - ARTL
37%
Loosely correlated
+1.78%
PALI - ARTL
34%
Loosely correlated
-0.98%
APLM - ARTL
31%
Poorly correlated
-5.84%
IGC - ARTL
30%
Poorly correlated
-0.98%
PHIO - ARTL
28%
Poorly correlated
-0.97%
More

PHIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHIO has been closely correlated with RIGL. These tickers have moved in lockstep 84% of the time. This A.I.-generated data suggests there is a high statistical probability that if PHIO jumps, then RIGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHIO
1D Price
Change %
PHIO100%
-0.97%
RIGL - PHIO
84%
Closely correlated
+3.02%
CLNN - PHIO
83%
Closely correlated
+1.34%
DARE - PHIO
81%
Closely correlated
+0.94%
IMRN - PHIO
71%
Closely correlated
-1.69%
TPST - PHIO
51%
Loosely correlated
+9.57%
More